Skin Substitute Therapy Products in Milwaukee, WI

The numbers that actually change how you stock in Milwaukee

CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Obesity 41.8%; arthritis 23.8%. Those three PLACES crude rates (plus Census 577,222) are the local facts on this page. Everything else is the national skin substitute therapy catalog and J6 paperwork.

The chart problems we still see in WI

• CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Adult obesity in Milwaukee is 41.8% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. A CTP without offloading and serial measurements still fails J6 review. Product is the last step, not the first.
• First Coast (Florida) is the only single-state MAC; every other state shares a contractor with neighbors. Wisconsin is J6 — copy-pasting a Florida LCD packet here is a denial pattern we still see.
• In a city of 500k–1M, vendor noise is the operational problem: too many look-alike allograft flyers, too little chain-of-custody paperwork. Hawk Medical ships nationwide with HCT/P documentation; we do not invent a Milwaukee street address.

Wisconsin Department of Health Services vs. the IFU

14.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 500k–1M with 577,222 residents will still mix those payers. CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.

A practical checklist for Milwaukee